IP Library Granted Patent US 8,163,938
Granted Patent B2
US 8,163,938 · App. 12/833,423 · Granted Apr 24, 2012

Aminocyclohexyl ether compounds and uses thereof

Assignee: Cardiome Pharma Corp.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,163,938
App. No.
12/833,423
Granted
Apr 24, 2012
Kind
B2
Abstract

Aminocyclohexyl ether compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses uses for the compounds and compositions, including the treatment of arrhythmia.

Claims (83)

1. A method of stereoselectively making an aminocyclohexyl ether comprising:

reacting a compound of formula (55),

or a compound of formula (74),

with a compound of formula (56),

to form a compound of formula (57),

or a compound of formula (75),

respectively,

wherein R 1 and R 2 , when taken together with the nitrogen atom to which they are directly attached in formula (57) or (75), form a ring denoted by formula (II):

wherein the method further comprises making the compound of formula (74) or formula (55) by activating a compound of formula (73),

or a compound of formula (94),

with a hydroxy activating reagent to form the compound of formula (74) or the compound of formula (55), respectively;

wherein the method further comprises making a compound of formula (73) by hydrogenating and hydrogenolyzing a compound of formula (72),

to form the compound of formula (73);

wherein the method further comprises making a compound of formula (72) by

alkylating a compound of formula (51),

with a compound of formula (54),

to form the compound of formula (72);

wherein X is a halide;

wherein O-J is a leaving group;

wherein R 3 , R 4 and R 5 are independently selected from hydrogen, hydroxy, and C 1 -C 6 alkoxy, with the proviso that R 3 , R 4 and R 5 cannot all be hydrogen; and

wherein O-Q is a leaving group that reacts with —OH in the compound of formula (51) to form the compound of formula (72), such that the stereochemical configuration of the compound of formula (51) is retained in the compound of formula (72).

2. A method of making a compound of compound of formula (93):

wherein the method comprises:

alkylating a compound of formula (92),

with a compound of formula (54),

to form the compound of formula (93);

wherein the method further comprises making a compound of formula (92) by

hydrogenating and hydrogenolyzing a compound of formula (91),

to form the compound of formula (92);

wherein Pro is a protecting group;

wherein X is a halide;

wherein R 3 R 4 and R 5 are independently selected from hydrogen, hydroxy, and C 1 -C 6 alkoxy, with the proviso that R 3 , R 4 and R 5 cannot all be hydrogen; and

wherein O-Q is a leaving group that reacts with —OH in the compound of formula (92) to form the compound of formula (93), such that the stereochemical configuration of the compound of formula (92) is retained in the compound of formula (93).

3. A method of stereoselectively making an aminocyclohexyl ether comprising:

reacting a compound of formula (55),

or a compound of formula (74),

with a compound of formula (56),

to form a compound of formula (57),

or a compound of formula (75),

respectively,

wherein R 1 and R 2 , when taken together with the nitrogen atom to which they are directly attached in formula (57) or (75), form a ring denoted by formula (II):

and

wherein the method further comprises making a compound of formula (55) or formula (74) by alkylating a compound of formula (53),

or a compound of formula (84),

with a compound of formula (54),

to form the compound of formula (55) or the compound of formula (74); respectively; and

optionally protecting the compound of formula (53) or the compound of formula (84), before said alkylating step;

wherein O-Q is a leaving group that reacts with —OH in formula (53) or formula (84) to form the compound of formula (55) or the compound of formula (74), such that the stereochemical configuration of the compound of formula (53) or the compound of formula (84) is retained in the compound of formula (55) or the compound of formula (74), respectively;

wherein the method further comprises making the compound of formula (53) by

hydrogenating and hydrogenolyzing a compound of formula (52),

to form the compound of formula (53);

wherein X is a halide;

wherein O-J is a leaving group; and

wherein R 3 R 4 and R 5 are independently selected from hydrogen, hydroxy, and C 1 -C 6 alkoxy, with the proviso that R 3 , R 4 and R 5 cannot all be hydrogen.

4. The method of claim 3 , wherein the method further comprises making a compound of formula (52):

wherein the method comprises:

activating a compound of formula (51),

with a hydroxy activating reagent to form the compound of formula (52);

wherein X is a halide; and

wherein O-J is a leaving group.

5. A method of making an aminocyclohexyl ether comprising:

reacting a compound of formula (55),

or a compound of formula (74),

with a compound of formula (56),

to form a compound of formula (57),

or a compound of formula (75),

respectively,

wherein R 1 and R 2 , when taken together with the nitrogen atom to which they are directly attached in formula (57) or (75), form a ring denoted by formula (II):

and

wherein the method further comprises stereoselectively making the aminocyclohexyl ether of formula (57) by

(a) hydrogenating and hydrogenolyzing a compound of formula (91),

to form a compound of formula (92),

wherein Pro is a protecting group and X is a halide;

(b) alkylating the compound of formula (92) with a compound of formula (54),

wherein R 3 , R 4 and R 5 are as defined above and O-Q is a leaving group that reacts with the hydroxy group in formula (92) to form a compound of formula (93),

such that the stereochemical configuration of the compound of formula (92) is retained in the compound of formula (93);

(c) deprotecting the compound of formula (93) to form a compound of formula (94),

(d) activating the compound of formula (94) to form a compound of formula (55),

wherein O-J is a leaving group; and

(e) reacting the compound of formula (55) with a compound of formula (56),

wherein R 1 and R 2 are as defined above, to form the aminocyclohexyl ether of formula (57);

wherein R 3 , R 4 and R 5 are independently selected from hydrogen, hydroxy and C 1 -C 6 alkoxy, with the proviso that R 3 , R 4 and R 5 cannot all be hydrogen; and

wherein O-J is a leaving group.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2020
From: JUNG, GRACE; PLOUVIER, BERTRAND M.C.; LIU, YUZHONG; ZHU, JEFF JIQUN; SHENG, TAO; BARRETT, ANTHONY G.M.; CHOI, LEWIS SIU LEUNG; CHOU, DOUG TA HUNG
To: CARDOIME PHARMA CORP.
Reel/Frame 052084/0833 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2018
From: CARDIOME PHARMA CORP.
To: CORREVIO CANADA CORP.
Reel/Frame 046831/0078 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2018
From: CORREVIO CANADA CORP.
To: CORREVIO INTERNATIONAL SÀRL
Reel/Frame 046831/0227 →
RELEASE OF SECURITY INTEREST Recorded Jun 20, 2016
From: MIDCAP FINANCIAL TRUST
To: CARDIOME PHARMA CORP.; CARDIOME, INC.; ARTESIAN THERAPEUTICS, INC.; MURK ACQUISITION SUB, INC.; CORREVIO LLC; CARDIOME INTERNATIONAL AG; CORREVIO INTERNATIONAL SARL; CORREVIO (UK) LTD.; CARDIOME UK LIMITED; CORREVIO (AUSTRALIA) PTY LTD.
Reel/Frame 038961/0202 →
SECURITY INTEREST Recorded Jul 24, 2014
From: CARDIOME PHARMA CORP.; CARDIOME, INC.; ARTESIAN THERAPEUTICS, INC.; MURK ACQUISITION SUB, INC.; CORREVIO LLC; CARDIOME INTERNATIONAL AG; CORREVIO INTERNATIONAL SARL; CORREVIO (UK) LTD.; CARDIOME UK LIMITED; CORREVIO (AUSTRALIA) PTY LTD.
To: MIDCAP FUNDING V, LLC
Reel/Frame 033407/0314 →
Continuity (10)
Continuation 11690361 · Mar 23, 2007
Continuation 10555364
Provisional Application 60467159 · May 2, 2003
Provisional Application 60476083 · Jun 4, 2003
Provisional Application 60475884 · Jun 5, 2003
Provisional Application 60475912 · Jun 5, 2003
Provisional Application 60476447 · Jun 5, 2003
Provisional Application 60489659 · Jul 23, 2003
Provisional Application 60493392 · Aug 7, 2003
Related Publication 20110004006A1 · Jan 6, 2011